CDC Contracts with SRA International for Select Agent Monitoring
The CDC’s Division of Select Agents and Toxins has awarded SRA International a $24.9 million contract to provide laboratory support services to the Select Agent Program. Awarded in September of 2008, the five-year contract is a recompete of work the company has supported since 2002 through the acquisition of Constella Group. Under the contract, SRA will continue to help CDC track the possession, use, and transfer of select agents in the U.S.